Dr Lal Share Price
₹1474.20
as on
Dr Lal Stock Performance
as on January 2, 2026 at 4:01 pm IST
Day's Low
Day's High
₹1,460.6₹1,509
0.92%
Downside
2.36%
Upside
52 Week's Low
52 Week's High
₹1,146.78₹1,77022.21%
Downside
20.07%
Upside
Dr Lal share price movements today
- Previous Close
- ₹1,509.80
- Open
- ₹1,509.00
- Volume
- 6.38L
- Upper Circuit
- ₹1,811.70
- Lower Circuit
- ₹1,207.90
- Day's Low - High
- ₹1,460.6 - ₹1,509
- 52 Week Low - High
- ₹1,146.78 - ₹1,770
Dr Lal Historical Returns
- 1 Month Return
- -1.56 %
- 3 Month Return
- -5.73 %
- 1 Year Return
- + 0.13 %
- 3 Year Return
- + 31.67 %
- 5 Year Return
- + 22.88 %
Dr Lal Fundamentals
as on January 2, 2026 at 4:01 pm IST
Market Cap
₹24,700.37 Cr
Return on Equity (ROE)
24.65
PE Ratio (TTM)
46
Return on capital employed (ROCE)
29.14
Industry PE ratio
49.25
Beta (LTM)
0.45
P/B Ratio
9.71
Dividend Yield
0.97
PEG Ratio
5.79
Quarterly Earnings Growth YOY
16.36
EPS (TTM)
29.445
Sector
Healthcare
Book Value
129.96
Technical Analysis
Bearish
View Technical Analysis
Dr Lal Stock Valuation
as on January 2, 2026 at 4:01 pm IST
Dr Lal in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (46.00x)
January 2, 2026
Industry (49.25x)
January 2, 2026
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 46.00x
Dr Lal Pathlabs Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dr Lal with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 24,700.37 | 4.58% | 0.54 | 492 | 2,461 | |
| HOLD | 59,735.13 | 41.59% | 0.71 | 354 | 5,553 | |
| HOLD | 66,866.73 | 17.7% | 0.59 | 2,216 | 12,964 | |
| BUY | 10,880.63 | 14.16% | 0.65 | 143 | 704 | |
| BUY | 7,308.70 | 9.49% | 0.53 | 90 | 687 |
Analyst Recommendation on Dr Lal Stock
Based on 26 analysts
65.38%
Buy
7.69%
Hold
26.92%
Sell
Based on 26 analysts, 65.38% of analysts recommend a 'BUY' rating for Dr Lal. Average target price of ₹1714.37
Source: S&P Global Market Intelligence
Dr Lal Share Price Target
Get share price movements and forecasts by analysts on Dr Lal.
What analysts predicted
16.29%UPSIDE
Target Price
₹1714.37
Current Price
₹1474.2
Analyzed by
26 Analysts
High
₹2000
Target
₹1714.37
Low
₹1200
Dr Lal target price ₹1714.37, a slight upside of 16.29% compared to current price of ₹1474.2. According to 26 analysts rating.
Source: S&P Global Market Intelligence
Dr Lal Stock’s Investor Sentiment and Interest
Investment in Dr Lal Pathlabs Ltd Shares on INDmoney has grown by 107.14% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:107.14% versus previous 30 day period
Search interest for Dr Lal Pathlabs Ltd Stock has increased by 79% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:79% versus previous 30 day period
Dr Lal Pathlabs Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Dr Lal Pathlabs Ltd Annual Profit & Loss
Figures in Rupees Crores
Dr Lal Pathlabs Ltd Cash Flow
Figures in Rupees Crores
Dr Lal Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Dr Lal Stock
Check out the Mutual Funds with significant holdings in Dr Lal.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Flexi Cap Fund -Direct Plan - Growth Option | 0.65% | 2000000 | |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.43% | 1200626 | |
 Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth | 1.01% | 823007 | |
 SBI Large & Midcap Fund Direct Growth | 0.54% | 650000 | |
 Nippon India Small Cap Fund - Direct Plan - Growth Plan | 0.29% | 645485 |
Dr Lal Corporate Actions
View detailed summary of the earnings and dividend history of Dr Lal.
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 16.41% since last year same period to ₹150.40Cr in the Q2 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated 13.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends October,2025
In the quarter ending September 2025, Dr Lal Pathlabs Ltd has declared dividend of ₹7.00 per share on 31 Oct 2025 - translating a dividend yield of 1.70%.
Read More about Dividends
Indices Featuring Dr Lal Stock
Check stock indices that include Dr Lal.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, LALPATHLAB stock has moved up by 3.2%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 21.68% to 21.86% in Sep 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 621.8 Cr → 755.4 Cr (in ₹), with an average increase of 6.2% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 132.4 Cr → 150.4 Cr (in ₹), with an average increase of 12.0% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 15.04% to 15.90% in Sep 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Narayana Hrudayalaya Ltd has given 46.6% return, outperforming this stock by 46.5%
- NO EFFECT
Against Peers
In the last 3 years, Fortis Healthcare Ltd has given 222.6% return, outperforming this stock by 190.9%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 53.79% to 53.22% in Sep 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.23% to 6.07% in Sep 2025 quarter
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹730.60Cr as on September 2025 (Q2 FY26)
Net Profit: ₹152.20Cr as on September 2025 (Q2 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| CEO | Arvind Lal |
| E-voting on shares | Click here to vote |
FAQs
What is Dr Lal share price today?
Dr Lal share price today stands at ₹1474.2 as on at the close of the market. Dr Lal share today touched a day high of ₹1509 and a low of ₹1460.6.
What is the 52 week high and 52 week low range for Dr Lal share?
Dr Lal touched a 52 week high of ₹1770 and a 52 week low of ₹1146.78. Dr Lal share price today i.e. is closed at ₹1474.2, which is -16.71% down from its 52 week high and 28.55% up from its 52 week low.
What is Dr Lal's market capitalisation today?
Dr Lal market capitalisation is ₹24,700.37 Cr as on .
How to buy Dr Lal shares?
To buy Dr Lal shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LALPATHLAB or Dr Lal Pathlabs Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Dr Lal shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Dr Lal trading volume today?
Dr Lal trading volume is 6.38L as on . This means that 6.38L shares of Dr Lal were bought and sold on the stock market during today's trading session.